CD38 and hepatocellular carcinoma: To investigate CD38 expression in HCC, we used CyTOF to profile PBMCs, NILs and TILs obtained from 17 HCC patients (Table S1) with an antibody panel of 41 surface and intracellular immune markers (Table S2).